Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Shuyao Ruan"'
Autor:
Yongtai Zhang, Qing Xia, Tong Wu, Zehui He, Yanyan Li, Zhe Li, Xuefeng Hou, Yuanzhi He, Shuyao Ruan, Zhi Wang, Jia Sun, Nianping Feng
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-23 (2021)
Abstract Background A red blood cell membrane (RBCm)-derived drug delivery system allows prolonged circulation of an antitumor treatment and overcomes the issue of accelerated blood clearance induced by PEGylation. However, RBCm-derived drug delivery
Externí odkaz:
https://doaj.org/article/53f226314d5949dc9f0b07b247563475
Autor:
Lina Shen, Xiaolin Hou, Zhi Wang, Teng Guo, Zehui He, Shuyao Ruan, Zhenda Liu, Hang Ruan, Yongtai Zhang, Nianping Feng
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 2062-2070 (2021)
To overcome the poor water solubility of total flavones of Arisaematis rhizoma, microemulsions (MEs) can be used as a carrier for transdermal administration to promote their solubilization and skin permeability. Here, we investigated the physical com
Externí odkaz:
https://doaj.org/article/2e68631a91ef4eeb991cdbb6b349f1d1
Publikováno v:
Pharmaceutics, Vol 13, Iss 8, p 1235 (2021)
Melittin is a promising antitumor substance; however, it is a nonspecific cytolytic peptide, which limits its clinical application. In this study, melittin liposomes (Mel-Lip) and hyaluronic acid (HA)-modified Mel-Lip (Mel-HA-Lip) were designed to re
Externí odkaz:
https://doaj.org/article/1a882571c9b24665aa763ec710ffc7e0
Autor:
Zhi Wang, Teng Guo, Jiaqi Li, Lixia Pei, Yongtai Zhang, Zehui He, Hang Ruan, Yuanzhi He, Nianping Feng, Tong Wu, Tianyuan Ci, Xiaolin Hou, Shuyao Ruan
Publikováno v:
ACS Nano. 15:20087-20104
Due to the lack of a delivery system that actively targets hypertrophic scar fibroblasts (HSFs), it is difficult to concentrate the effects of drugs on hypertrophic scars (HSs). We recently discovered that the HSF membrane has a homologous targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc79cc3b5509afaf99616db5dfc7d4a3
https://doi.org/10.1021/acsnano.1c07829
https://doi.org/10.1021/acsnano.1c07829
Autor:
Yanyan Li, Shuyao Ruan, Jingwen Guo, Zehui He, Qing Xia, Tong Wu, Zhi Wang, Zhe Li, Hongmei Hu, Qian Jing, Xuefeng Hou, Yuanzhi He, Beibei Zhang, Nianping Feng, Yongtai Zhang
Publikováno v:
Molecular pharmaceutics. 19(8)
Some cancer cell membrane (CCM)-derived nanovesicles show strong homing effects and are used for targeted cancer therapy. By co-constructing the B16F10 cell membrane with a PEGylated phospholipid membrane, a new nanocarrier with a composite nanocrown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfb30e44699ff8c0be18a5164c7cd593
https://pubmed.ncbi.nlm.nih.gov/35850109
https://pubmed.ncbi.nlm.nih.gov/35850109
Publikováno v:
Biomaterials science. 9(24)
The greatest limitation in the development of transdermal drug delivery systems is that only a few drugs can permeate the skin due to the barrier function of the stratum corneum. Active and passive methods are generally available for improving the ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83a4eb146571e1e1163b79ea2c32eaad
https://pubmed.ncbi.nlm.nih.gov/34752590
https://pubmed.ncbi.nlm.nih.gov/34752590
Autor:
Jia Sun, Yuanzhi He, Yongtai Zhang, Zhi Wang, Zehui He, Tong Wu, Xuefeng Hou, Shuyao Ruan, Qing Xia, Nianping Feng, Zhe Li, Yanyan Li
Publikováno v:
Journal of Nanobiotechnology
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-23 (2021)
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-23 (2021)
BackgroundA red blood cell membrane (RBCm)-derived drug delivery system allows prolonged circulation of an antitumor treatment and overcomes the issue of accelerated blood clearance induced by PEGylation. However, RBCm-derived drug delivery systems a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f778c01fcfbc22542b4d653cca07ce
https://doi.org/10.1186/s12951-021-00977-3
https://doi.org/10.1186/s12951-021-00977-3
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 13, Iss 1235, p 1235 (2021)
Pharmaceutics, Vol 13, Iss 1235, p 1235 (2021)
Melittin is a promising antitumor substance; however, it is a nonspecific cytolytic peptide, which limits its clinical application. In this study, melittin liposomes (Mel-Lip) and hyaluronic acid (HA)-modified Mel-Lip (Mel-HA-Lip) were designed to re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c82f658ac4276bb4cb259f3b9e143f
https://doi.org/10.3390/pharmaceutics13081235
https://doi.org/10.3390/pharmaceutics13081235
Autor:
Tong Wu, Xiaolin Hou, Jiaqi Li, Hang Ruan, Lixia Pei, Teng Guo, Zhi Wang, Tianyuan Ci, Shuyao Ruan, Yuanzhi He, Zehui He, Nianping Feng, Yongtai Zhang
Publikováno v:
ACS Nano; 12/28/2021, Vol. 15 Issue 12, p20087-20104, 18p